These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15960412)

  • 21. Ibuprofen and increased morbidity in children with asthma: fact or fiction?
    Kauffman RE; Lieh-Lai M
    Paediatr Drugs; 2004; 6(5):267-72. PubMed ID: 15449966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New pathophysiological concepts on aspirin hypersensitivity (Widal syndrome); diagnostic and therapeutic consequences].
    de Weck A; Sanz ML; Gamboa P
    Bull Acad Natl Med; 2005 Jun; 189(6):1201-18; discussion 1218-20. PubMed ID: 16433444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin Exacerbated Respiratory Disease.
    Fruth K; Gosepath J
    Adv Otorhinolaryngol; 2016; 79():21-8. PubMed ID: 27466843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease.
    Woessner KM; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):339-44. PubMed ID: 15521369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin-induced asthma: clinical aspects, pathogenesis and management.
    Hamad AM; Sutcliffe AM; Knox AJ
    Drugs; 2004; 64(21):2417-32. PubMed ID: 15482000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Forty years of ibuprofen use.
    Moore N
    Int J Clin Pract Suppl; 2003 Apr; (135):28-31. PubMed ID: 12723744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
    Walters KM; Waldram JD; Woessner KM; White AA
    Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NSAID-induced bronchospasm--a common and serious problem. A report from MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority.
    Sturtevant J
    N Z Dent J; 1999 Sep; 95(421):84. PubMed ID: 10561993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study.
    Bavbek S; Dursun AB; Dursun E; Eryilmaz A; Misirligil Z
    Int Arch Allergy Immunol; 2007; 142(1):64-9. PubMed ID: 17016059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
    Bavbek S; Yilmaz I; Celik G; Aydin O; Erkekol FÖ; Orman A; Kurt E; Ediger D; Dursun B; Abadoğlu O; Ozşeker F; Akkaya E; Karakiş GP; Canbakan S; Yüksel S; Misirligil Z
    Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
    Berges-Gimeno MP; Simon RA; Stevenson DD
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of parecoxib in asthmatic patients with aspirin-exacerbated respiratory disease.
    Valero A; Sánchez-López J; Bartra J; Serrano C; Muñoz-Cano R; Roca J; Picado C
    Int Arch Allergy Immunol; 2011; 156(2):221-3. PubMed ID: 21597303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural history and clinical features of aspirin-exacerbated respiratory disease.
    Fahrenholz JM
    Clin Rev Allergy Immunol; 2003 Apr; 24(2):113-24. PubMed ID: 12668892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity.
    Morales DR; Guthrie B; Lipworth BJ; Jackson C; Donnan PT; Santiago VH
    Allergy; 2015 Jul; 70(7):828-35. PubMed ID: 25855099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation.
    Picado C; Castillo JA; Montserrat JM; Agusti-Vidal A
    Eur Respir J; 1989 Feb; 2(2):127-9. PubMed ID: 2703041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper.
    Kowalski ML; Agache I; Bavbek S; Bakirtas A; Blanca M; Bochenek G; Bonini M; Heffler E; Klimek L; Laidlaw TM; Mullol J; Niżankowska-Mogilnicka E; Park HS; Sanak M; Sanchez-Borges M; Sanchez-Garcia S; Scadding G; Taniguchi M; Torres MJ; White AA; Wardzyńska A
    Allergy; 2019 Jan; 74(1):28-39. PubMed ID: 30216468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nimesulide in the treatment of patients intolerant of aspirin and other NSAIDs.
    Senna GE; Passalacqua G; Andri G; Dama AR; Albano M; Fregonese L; Andri L
    Drug Saf; 1996 Feb; 14(2):94-103. PubMed ID: 8852524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.